cd38 inhibitor and 5-amino-1mq synergy nad+ as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions Targeting CD38 in Neoplasms and
Targeting CD38 in Neoplasms and Non Cancer Diseases Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




